H. Yu, X. Mei, X. Zhang, N. Qian, Q. Yu, and H. Zhou, “SLC39A1 contributes to gemcitabine resistance of pancreatic ductal adenocarcinoma by activating AMPK signaling”, Bangladesh J Pharmacol, vol. 19, no. 2, pp. 52–58, Jun. 2024.